IL-21 protein is one of the primary immunomodulators that regulates various immune responses by influencing multiple immune cells. This protein belongs to the type I cytokine family and exhibits pleiotropic effects in tumor immunotherapy. Cytokines are critical factors in modulating diverse immune responses and play key roles in disease induction, initiation, progression, and alleviation. Understanding the mechanisms by cytokines regulate disease states can aid in designing novel therapeutic strategies. IL-21 protein binds to its receptor, activating downstream signaling pathways, which are significant for the proliferation and differentiation of T cells, B cells, and natural killer cells. The TR-FRET IL-21/IL-21R assay kit can be used to quantitatively measure the binding activity of IL-21 to its receptor, providing a technical tool for studying this signaling pathway.
The IL-21 receptor is encoded by the IL-21R gene and belongs to the type I cytokine receptor family. This receptor forms a heterodimeric receptor complex with the common γ-chain, which also serves as a co-receptor for IL-2, IL-4, IL-7, IL-9, and IL-15. Ligand binding to the IL-21 receptor leads to the activation of multiple downstream signaling molecules, including JAK1, JAK3, STAT1, and STAT3. The receptor plays a crucial role in regulating immunoglobulin production, a conclusion supported by studies in IL-21 receptor knockout mice. TR-FRET technology can be applied to study conformational changes in IL-21 and IL-21R after binding, assessing dynamic alterations in receptor-ligand interactions under various conditions.
Upon binding to its receptor, IL-21 protein activates multiple downstream signaling pathways, primarily including the JAK-STAT pathway, PI3K pathway, and MAPK pathway. The JAK-STAT pathway is the core route for IL-21 signal transduction, with STAT3 playing a dominant role in IL-21's biological effects, while STAT1 also participates in IL-21-regulated gene expression. The balance between STAT1 and STAT3 is critical for the fine-tuned regulation of IL-21 functions. The MAPK and PI3K pathways contribute to IL-21-mediated proliferative effects. These signaling pathways interconnect to form a complex regulatory network that collectively mediates the diverse biological functions of IL-21 protein. The TR-FRET IL-21/IL-21R assay kit can be used to study the impact of IL-21-receptor binding on downstream pathway activation, providing quantitative analysis tools for understanding signal transduction mechanisms.
IL-21 protein modulates antitumor immune responses by influencing various immune cells. It promotes the proliferation and effector functions of CD8-positive T cells, enhancing their cytotoxic activity. In natural killer cells, IL-21 facilitates maturation, differentiation, and cytokine secretion, improving their ability to kill tumor cells. In B cells, IL-21 regulates immunoglobulin production and class switching, influencing humoral immune responses. These pleiotropic effects make IL-21 a promising candidate for tumor immunotherapy. Studies have shown that activation of the IL-21 signaling pathway can enhance antitumor immune responses, inhibiting tumor growth and metastasis. TR-FRET technology can be applied to screen molecules that modulate IL-21-receptor binding, supporting the development of novel immunotherapeutic strategies.
The intensity and duration of IL-21 signaling are regulated by multiple factors. Receptor expression levels vary among immune cell subsets, affecting their responsiveness to IL-21. The availability of the common γ-chain, a shared subunit among multiple cytokine receptors, is competitively regulated by other cytokine signals. Negative feedback mechanisms, such as the induction of SOCS proteins, can suppress excessive JAK-STAT signaling. The balance between STAT1 and STAT3 is crucial for the fine-tuned regulation of IL-21 functions, determining whether IL-21 promotes cell proliferation, differentiation, or apoptosis. The TR-FRET IL-21/IL-21R assay kit can be used to evaluate the effects of various regulatory factors on IL-21-receptor binding, assessing dynamic changes in receptor-ligand interactions.
Given the pleiotropic effects of IL-21 protein in immunoregulation, strategies targeting the IL-21 signaling pathway have garnered attention in tumor immunotherapy. Recombinant IL-21 protein can directly activate immune cells, enhancing antitumor immune responses. Combining IL-21 with other cytokines, such as IL-15, can produce synergistic effects, further improving therapeutic outcomes. Additionally, genetically engineering CAR-T cells to express IL-21 can enhance their proliferative capacity and persistence, improving treatment efficacy. While activating the IL-21 signaling pathway boosts antitumor immunity, it may also contribute to autoimmune disease pathogenesis, necessitating precise modulation. TR-FRET technology can be applied to assess the impact of various intervention strategies on IL-21-receptor binding, providing quantitative methods for drug screening and dose optimization.
IL-21 protein, as one of the primary immunomodulators, holds significant potential in tumor immunotherapy. By activating multiple signaling pathways, including JAK-STAT, PI3K, and MAPK, it regulates the functions of T cells, B cells, and natural killer cells, enhancing antitumor immune responses. The TR-FRET IL-21/IL-21R assay kit provides a sensitive and efficient detection tool for studying the IL-21 signaling pathway, applicable to molecular mechanism research and drug screening. High-throughput screening systems based on TR-FRET technology will accelerate the discovery of drugs targeting the IL-21/IL-21R signaling pathway.
Nanjing UA-Bio Technology Co., Ltd. has independently developed the "UniOne® TR-FRET Human IL21/IL21R Binding Kit" (Catalog No.: UA086015), a high-performance analytical platform specifically designed for studying the interaction between interleukin-21 (IL-21) and its receptor IL-21R. This kit utilizes time-resolved fluorescence resonance energy transfer (TR-FRET) technology to accurately and efficiently evaluate the binding activity of human IL-21 to IL-21R, providing a stable and standardized solution for research in tumor immunotherapy, autoimmune disease mechanisms, and immune cell therapy development.
| Core Advantages | Detailed Parameters / Functional Description |
|---|---|
| High Purity and Full Biological Activity | The kit's core components include high-purity, biologically active human IL-21 protein and IL-21R, validated through multi-dimensional quality control. Both maintain the correct natural four-helix bundle conformation and intact binding functionality, accurately simulating the high-affinity binding of IL-21 to IL-21R under physiological conditions, ensuring experimental accuracy, reproducibility, and functional relevance. |
| Exceptional Batch-to-Batch Consistency and Stability | Leveraging an internationally leading protein expression platform and highly standardized production processes, combined with a stringent quality control system, the product exhibits outstanding long-term stability and excellent batch-to-batch consistency, providing reliable quality assurance for long-term and continuous drug screening and mechanistic research. |
| Ready-to-Use Flexible Experimental Platform | This kit employs a homogeneous TR-FRET technology with a simple "add-mix-read" workflow, eliminating the need for cumbersome washing steps. Its optimized formulation is compatible with multi-well plate (96/384-well) automation platforms, making it suitable for various applications such as anti-IL-21 antibody/antagonist screening, receptor blocker evaluation, competitive binding assays, affinity analysis, and biosimilar activity assessment. |
| Comprehensive Solutions and Professional Support | We provide fully validated standard protocols, typical dose-response curves, and detailed result interpretation guidelines to help establish stable and reproducible experimental workflows. Nanjing UA-Bio's professional technical team offers comprehensive support for research design, experimental optimization, and data analysis. |
Nanjing UA-Bio Technology Co., Ltd. is dedicated to providing cutting-edge, high-quality core reagents and tools for immunology, cell therapy, and innovative drug development. For detailed technical parameters, validation data, or specific application inquiries regarding the "UniOne® TR-FRET Human IL21/IL21R Binding Kit" (Catalog No.: UA086015), please feel free to contact us.
